Spanish Red Biotech Pipeline

CIBER

COMPOUNDS FOR TREATING HELICOBACTER PYLORI AND CAMPYLOBACTER JEJUNI INFECTION

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: The present invention describes new bioactive compounds with antimicrobial activity against Helicobacter pylori (H. pylori) and Campylobacter jejuni (C. jejuni) by acting specifically on the protein HsrA (essential for cell viability).
Phase: 1Non Regulatory Preclinical